News for Savient Pharmaceuticals Inc - Google Finance

Savient Pharmaceuticals Inc (NASDAQ:SVNT) focus on commercializing ...

Tue, 18 Jun 2013 10:37:07 GMT

Savient Pharmaceuticals Inc (NASDAQ:SVNT) focus on commercializing ...
NYSE Post - Jun 18, 2013

Boston, MA, 06/18/2013 (nysepost) - The share prices of Savient Pharmaceuticals Inc (NASDAQ:SVNT) had been traded in the price range of $0.74 and $0.84 per share on Monday.

Savient Pharmaceuticals Inc. (NASDAQ:SVNT) Rallies after Drug Price Hike

Thu, 13 Jun 2013 19:04:24 GMT

Savient Pharmaceuticals Inc. (NASDAQ:SVNT) Rallies after Drug Price Hike
GSPInsider - Jun 13, 2013

Northern, WI 06/13/2013 (GDPInsider) - Savient Pharmaceuticals Inc. (NASDAQ:SVNT) has been having a solid day in today's trading session after opening at 0.71, 0.01 cent above its previous close of 0.70.

SAVIENT PHARMACEUTICALS INC : Savient Pharmaceuticals to Present New ...

Wed, 12 Jun 2013 12:06:54 GMT

SAVIENT PHARMACEUTICALS INC : Savient Pharmaceuticals to Present New ...
4-traders (press release) - Jun 12, 2013

BRIDGEWATER, N.J., June 12, 2013 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that ongoing KRYSTEXXA(® )(pegloticase) post-marketing surveillance data describing the long-term safety data for KRYSTEXXA will be ...

Savient Pharmaceuticals Inc (NASDAQ:SVNT) down by 5.44%, Golden Star ...

Fri, 07 Jun 2013 19:14:45 GMT

Savient Pharmaceuticals Inc (NASDAQ:SVNT) down by 5.44%, Golden Star ...
NIS - Jun 7, 2013

New York, NY - (NISMAGAZINE) - 06/07/2013- Savient Pharmaceuticals Inc (NASDAQ:SVNT) is down by 5.44% to trade at $0.728, with a volume of 0.917 million shares.

Savient Pharmaceuticals Inc (NASDAQ:SVNT) up by 1.63%, Cytokinetics Inc ...

Tue, 28 May 2013 19:08:20 GMT

Savient Pharmaceuticals Inc (NASDAQ:SVNT) up by 1.63%, Cytokinetics Inc ...
NIS - May 28, 2013

New York, NY - (NISMAGAZINE) - 5/28/2013- Savient Pharmaceuticals Inc (NASDAQ:SVNT) Tuesday's trading session saw Savient Pharmaceuticals Inc (NASDAQ:SVNT) up by 1.63%. It opened at a price of $0.57 which reached an intraday high of $0.59 ...

Everybody, Time to Get Back on Board the Savient Pharmaceuticals (SVNT) Train

Fri, 14 Jun 2013 15:27:27 GMT

Everybody, Time to Get Back on Board the Savient Pharmaceuticals (SVNT) Train
SmallCap Network - Jun 14, 2013

Way back on September 25th, before the market opened, I penned some less than optimistic comments on Savient Pharmaceuticals, Inc. (NASDAQ:SVNT), which is to say I expected the stock to start falling back after the 360% runup it had managed to make ...

Savient Pharmaceuticals Lowered to "Market Perform" at William Blair (SVNT)

Tue, 21 May 2013 16:39:00 GMT

Savient Pharmaceuticals Lowered to "Market Perform" at William Blair (SVNT)
Daily Political - May 21, 2013

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) is a specialty biopharmaceutical company focused on developing KRYSTEXXA (pegloticase), or KRYSTEXXA, for the treatment of chronic gout in patients refractory to conventional therapy.

Best 5 & Worst 5 Biotech Stocks: Infinity, Savient, Hemispherx BioPharma ...

Wed, 05 Jun 2013 12:13:36 GMT

Best 5 & Worst 5 Biotech Stocks: Infinity, Savient, Hemispherx BioPharma ...
REM - Jun 5, 2013

Savient Pharmaceuticals Inc (NASDAQ:SVNT) rose 14.34% to $0.654 on volume of 2.09M shares versus average-daily volume of 507,566.00 shares.

Stocks Upgraded, Luxottica, F5, Lloyds, Great Plains, Qlik, IMAX, Emulex ...

Mon, 17 Jun 2013 14:33:21 GMT

Stocks Upgraded, Luxottica, F5, Lloyds, Great Plains, Qlik, IMAX, Emulex ...
PR Carbon (press release) - Jun 17, 2013

Stock of Savient Pharmaceuticals Inc (NASDAQ:SVNT) lifted to Market Perform from Underperform by Leerink Swann. REITs: National Retail Properties, Inc. (NYSE:NNN) and Biomed Realty Trust Inc (NYSE:BMR) both are raised to Buy from Hold at Jefferies.

Best 5 & Worst 5 Biotech Stocks: ACADIA, ZIOPHARM, AVEO, Savient, Celldex ...

Tue, 11 Jun 2013 12:05:53 GMT

Best 5 & Worst 5 Biotech Stocks: ACADIA, ZIOPHARM, AVEO, Savient, Celldex ...
REM - Jun 11, 2013

Savient Pharmaceuticals Inc(NASDAQ:SVNT) rose 5.41% to $0.740 on volume of 1.57M shares versus average-daily volume of 863,952.00 shares, seemingly on a technical play as there was no major news.